Home › Funds › NEXTBio Capital Management LP › VSTM
NEXTBio Capital Management LP position in VSTM
VERASTEM INC · Health Care
NEXTBio Capital Management LP reported holding 906,742 shares of VSTM (VERASTEM INC) in its Q3 2026 13F filing — a position valued at US$7.3M, representing 3.18% of its reported portfolio and ranking #13 among its reported holdings. NEXTBio Capital Management LP has disclosed VSTM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NEXTBio Capital Management LP's VSTM position evolved
NEXTBio Capital Management LP first disclosed a stake in VSTM in Q4 2025 at 1,307,330 shares (US$10.1M). Across 4 filings, NEXTBio Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 906,742 shares valued at US$7.3M — a reduction of -400,058 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.31M | $10.09M | New |
| Q1 2026 | 1.31M | $6.93M | Hold |
| Q2 2026 | 1.31M | $4.99M | Hold |
| Q3 2026 | 906.74K | $7.30M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VSTM and 13F data
VSTM (VERASTEM INC) is a Health Care company. 42 other funds we track also report a position in VSTM — the largest reported positions include ARMISTICE CAPITAL, LLC (US$26.8M), Rosalind Advisors, Inc. (US$15.2M), Nantahala Capital Management, LLC (US$13.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VSTM
- ARMISTICE CAPITAL, LLC 7.02M sh · $26.83M · Q2 2026
- Rosalind Advisors, Inc. 3.99M sh · $15.23M · Q2 2026
- Nantahala Capital Management, LLC 3.58M sh · $13.69M · Q2 2026
- Stonepine Capital Management, LLC 3.35M sh · $12.80M · Q2 2026
- Foresite Capital Management VI LLC 3.15M sh · $12.02M · Q2 2026
- AIGH Capital Management LLC 1.12M sh · $9.03M · Q3 2026
- Opaleye Management Inc. 1.80M sh · $6.88M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.47M sh · $5.61M · Q2 2026
- TORRAY INVESTMENT PARTNERS LLC 464.38K sh · $3.74M · Q3 2026
- Virtus Investment Advisers, LLC 411.10K sh · $3.31M · Q3 2026
More on NEXTBio Capital Management LP
FAQ
How long has NEXTBio Capital Management LP held VSTM?
NEXTBio Capital Management LP has disclosed VSTM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is NEXTBio Capital Management LP's current position in VSTM?
As of Q3 2026, NEXTBio Capital Management LP holds 906.74K shares of VSTM (VERASTEM INC), valued at $7.30M, representing 3.18% of its reported portfolio and ranking #13.
Has NEXTBio Capital Management LP been buying or selling VSTM?
In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP reduced its position in VSTM.
Which other funds hold VSTM?
Other major institutional holders of VSTM include ARMISTICE CAPITAL, LLC, Rosalind Advisors, Inc., Nantahala Capital Management, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.